DNA Script Expands On-Demand Enzymatic DNA Synthesis to India Through Imperial Life Sciences Partnership
核心洞察
DNA Script (搜索) has signed a distribution agreement with Imperial Life Sciences (搜索) to bring its SYNTAX enzymatic DNA synthesis platform to researchers across India.
The SYNTAX platform enables laboratories to synthesize up to 384 high-quality ssDNA oligonucleotides in parallel within hours, eliminating reliance on external suppliers.
Imperial Life Sciences (搜索) brings over three decades of experience and an established nationwide network across Indian academic, biotech, and pharmaceutical institutions.
DNA Script (搜索), the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, has announced a new distribution agreement with Imperial Life Sciences (搜索) (ILS) to expand access to its SYNTAX platform across India. The partnership aims to equip Indian researchers with on-demand, in-house DNA synthesis capabilities, addressing long-standing bottlenecks in oligonucleotide procurement that have historically slowed scientific progress.
Under the agreement, ILS will distribute DNA Script (搜索)'s SYNTAX platform throughout India, providing local sales, technical support, and application expertise to researchers seeking faster, more flexible access to high-quality single-stranded DNA (ssDNA) oligonucleotides.
Addressing Supply Chain Bottlenecks in Life Sciences Research
Oligonucleotides are essential components of life sciences research, yet many researchers continue to rely on external suppliers, resulting in delays that can slow scientific progress and extend development timelines. DNA Script (搜索)'s automated benchtop SYNTAX platform addresses these challenges by enabling researchers to synthesize ssDNA oligonucleotides directly within their laboratories in just a few hours.
By shifting DNA production from centralized manufacturing facilities to the laboratory bench, researchers gain greater control over workflows, faster turnaround times, and reduced dependence on complex supply chains. The platform combines DNA synthesis, purification, and normalization in a single automated workflow, allowing laboratories to produce up to 384 oligonucleotides in parallel and accelerate design-build-test cycles across a wide range of research applications.
Strategic Expansion into a High-Growth Market
India is one of the world's fastest-growing biotechnology markets, creating increasing demand for technologies that accelerate research and reduce reliance on overseas supply chains. The agreement with ILS builds on DNA Script (搜索)'s recent expansion of its global distribution network across Latin America and East Asia, extending the availability of the SYNTAX platform into another key growth market for life sciences research.
With over three decades of experience supporting India's research community, ILS brings an established nationwide network spanning academic institutions, biotechnology companies, pharmaceutical organizations, and research laboratories.
Leadership Perspectives
Marc Montserrat, Chief Executive Officer of DNA Script (搜索), emphasized the strategic importance of the Indian market: "India's life sciences sector is moving fast, and researchers need the tools to match that pace. Partnering with Imperial Life Sciences (搜索) means laboratories across India can now access SYNTAX locally, with the speed, quality and scalability their research demands. Together, we are helping researchers reduce reliance on external DNA supply chains and accelerate scientific discovery through on-demand, in-house DNA synthesis."
Neeraj Gupta, Director of Sales at Imperial Life Sciences (搜索), highlighted the transformative potential of the technology for Indian researchers: "We are excited to partner with DNA Script (搜索) to bring the SYNTAX platform to researchers across India. This innovative technology empowers scientists to accelerate research by reducing dependency on external oligo supplies and significantly shortening the design-build-test cycle. By combining DNA Script's enzymatic DNA synthesis technology with our nationwide reach and technical expertise, we look forward to supporting India's growing genomics, synthetic biology and biotechnology communities with faster and more flexible access to DNA."
Enzymatic DNA Synthesis: A Next-Generation Approach
DNA Script (搜索)'s enzymatic DNA synthesis technology represents a departure from traditional chemical synthesis methods, offering a programmable biology approach that enables decentralized, on-demand DNA production. The partnership supports the company's broader strategy to broaden adoption of decentralized DNA synthesis and strengthen access to DNA production capabilities in rapidly growing research ecosystems worldwide.